VEGF traps and therapeutic uses thereof

Details for Australian Patent Application No. 2004252175 (hide)

Owner Regeneron Pharmaceuticals, Inc.

Inventors Daly, Thomas J.; Papadopoulos, Nicholas J.; Fandl, James P.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004252175

PCT Pub. Number WO2005/000895

Priority 10/609,775 30.06.03 US

Filing date 29 June 2004

Wipo publication date 6 January 2005

Acceptance publication date 22 July 2010

International Classifications

C07K 14/71 (2006.01) Peptides having more than 20 amino acids

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

A61P 27/02 (2006.01) Drugs for disorders of the senses

C07H 21/00 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

12 January 2006 PCT application entered the National Phase

  PCT publication WO2005/000895 Priority application(s): WO2005/000895

22 July 2010 Application Accepted

  Published as AU-B-2004252175

18 November 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004252178-High temperature process

2004252174-Compositions of lipopeptide antibiotic derivatives and methods of use thereof